Bronchial hypersensitivity in asthmatics in long-term symptom-free state.
case_control · Level III
Where this comes from
- Record sourced from PubMed, PMID 8432121.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Improvement of asthmatic symptoms was shown to be closely associated with a decrease in bronchial hypersensitivity to histamine inhalation. Thus, the patients' clinical backgrounds were compared between 26 long-term cases whose symptom-free state lasted more than 1 year and 15 short-term cases whose symptom-free state ceased within 1 year. Among backgrounds, only the intrinsic type of asthma was significantly higher in number in the long-term group than in short-term group (65 percent vs 27 percent). The histamine threshold after the patients became symptom-free was significantly higher in the long-term group. In the short-term group, the values of PC20 just before the termination of the symptom-free state were all less than 5,000 mg/L of histamine. However, in the long-term group, the values of the PC20 for the final test were mostly over 5,000 mg/L. Decrease in bronchial hypersensitivity is considered to be a very important aim of therapy in bronchial asthma.
Medical subject headings
- Asthma
- Bronchial Hyperreactivity